Cellink

Cellink is a bioconvergence company based in Gothenburg, Sweden, focused on enhancing biology research by designing and supplying innovative technologies and services. The company develops 3D bioprinters, bioinks, and other advanced equipment that enable researchers to conduct cell line development, perform high-throughput drug screening, fabricate realistic disease models, and print human tissues and organs for medical and pharmaceutical applications.

Cellink's product offerings include the BIO X series of 3D bioprinters, which allow printing with multiple cell types and biomaterials simultaneously. Their patented Clean Chamber Technology ensures a sterile environment for bioprinting. The company pioneered the development of a universal bioink, a printing material compatible with various bioprinting systems and cell types.

Cellink's technology finds applications in tissue engineering, regenerative medicine, cancer biology, and drug development. Their bioprinters can fabricate complex tissue models, such as trilayered skin constructs with vascular networks, sweat glands, and hair follicles, or metabolic tissue models with hepatocytes, stellate cells, and supporting structures like arterial and biliary ducts. These advanced models enable researchers to conduct more realistic drug testing and study disease progression.

In September 2021, Cellink was acquired by BICO Group AB for approximately USD 15 million, becoming a subsidiary within BICO's Bioprinting business area. After the acquisition, Cellink continued operating under its name in San Diego.